Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis, before and after successful therapy with infliximab: evaluation of a new scoring system. - Wikidata - wikimedia - TriplyDB

Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis, before and after successful therapy with infliximab: evaluation of a new scoring system.

Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis, before and after successful therapy with infliximab: evaluation of a new scoring system.

http://www.wikidata.org/entity/Q44398382

about

Magnetic resonance imaging in psoriatic arthritis: a review of the literature Efficacy of infliximab on MRI-determined bone oedema in psoriatic arthritis Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab Golimumab in radiographic and nonradiographic axial spondyloarthritis: a review of clinical trials Spanish Rheumatology Society and Hospital Pharmacy Society Consensus on recommendations for biologics optimization in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis Updating the OMERACT filter: implications for imaging and soluble biomarkers Anti-TNF-alpha therapy in ankylosing spondylitis.Whole body MR imaging in ankylosing spondylitis: a descriptive pilot study in patients with suspected early and active confirmed ankylosing spondylitis.The Nonradiographic Axial Spondyloarthritis, the Radiographic Axial Spondyloarthritis, and Ankylosing Spondylitis: The Tangled Skein of Rheumatology.Discovertebral (Andersson) lesions in severe ankylosing spondylitis: a study using MRI and conventional radiography.Measurement and treatment of radiographic progression in ankylosing spondylitis: lessons learned from observational studies and clinical trials.International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis Update on the treatment of ankylosing spondylitis.Spondyloarthritides: evolving therapies Natural history and clinical significance of MRI-detected bone marrow lesions at the knee: a prospective study in community dwelling older adults.Prediction of a major clinical response (BASDAI 50) to tumour necrosis factor alpha blockers in ankylosing spondylitis.Analysing chronic spinal changes in ankylosing spondylitis: a systematic comparison of conventional x rays with magnetic resonance imaging using established and new scoring systems Radiographic progression in patients with ankylosing spondylitis after 2 years of treatment with the tumour necrosis factor alpha antibody infliximab.Infliximab in combination with methotrexate in active ankylosing spondylitis: a clinical and imaging study.Histological evidence that infliximab treatment leads to downregulation of inflammation and tissue remodelling of the synovial membrane in spondyloarthropathy.Inflammation in ankylosing spondylitis: a systematic description of the extent and frequency of acute spinal changes using magnetic resonance imaging Assessment of acute spinal inflammation in patients with ankylosing spondylitis by magnetic resonance imaging: a comparison between contrast enhanced T1 and short tau inversion recovery (STIR) sequences.Sarilumab for the treatment of ankylosing spondylitis: results of a Phase II, randomised, double-blind, placebo-controlled study (ALIGN)What is MRI bone oedema in rheumatoid arthritis and why does it matter?First update of the international ASAS consensus statement for the use of anti-TNF agents in patients with ankylosing spondylitis.ASAS/EULAR recommendations for the management of ankylosing spondylitis.Immunohistological examination of open sacroiliac biopsies of patients with ankylosing spondylitis: detection of tumour necrosis factor alpha in two patients with early disease and transforming growth factor beta in three more advanced cases.Outcomes in ankylosing spondylitis: what makes the assessment of treatment effects in ankylosing spondylitis different?Early referral recommendations for ankylosing spondylitis (including pre-radiographic and radiographic forms) in primary care.Golimumab reduces spinal inflammation in ankylosing spondylitis: MRI results of the randomised, placebo- controlled GO-RAISE study Infliximab for the treatment of ankylosing spondylitis.Therapy of ankylosing spondylitis--a review. Part I: Conventional medical treatment and surgical therapy.Therapy of ankylosing spondylitis. Part II: biological therapies in the spondyloarthritides.How early should ankylosing spondylitis be treated with tumour necrosis factor blockers?Pharmacological management of undifferentiated spondyloarthropathies.Vertebral body corner oedema vs gadolinium enhancement as biomarkers of active spinal inflammation in ankylosing spondylitis.Developments and current pharmacotherapeutic recommendations for ankylosing spondylitis.Early diagnosis of spondyloarthritis.Biologic Treatment Registry Across Canada (BioTRAC): a multicentre, prospective, observational study of patients treated with infliximab for ankylosing spondylitis.Clinimetric properties of the ASAS health index in a cohort of Italian patients with axial spondyloarthritis.

P2860

Q22000866-B0F66AEF-0A8C-4ABE-B0A1-748D66EDF596 Q24674877-9B60583C-AF71-45A5-9912-9514DC17F9EF Q24816557-9E45260D-B3D0-4216-BF3A-CA9381C67F50 Q26738520-E4A49F49-B8F2-4274-9F54-412E895DD746 Q26852081-4042E03A-2D2D-481C-B600-B45C6C109D3A Q27014889-5062F24F-1C97-4589-A736-33A488F05D03 Q33204138-C87176AF-A2F4-4D22-AC5B-DEB4A9EB99BE Q33275865-10F21C06-8A65-4E7E-8FEB-82A6A2BD7742 Q33710428-5684A0FE-8438-44F0-A7CB-64B1971242FF Q34268747-05F09B40-A732-45B1-979A-690D9CA5F101 Q34403448-54193FBA-8D68-41ED-90ED-52F0BF312AC4 Q34536278-CFD30E8E-DF21-4AEE-B810-D95B9DDFD1AF Q34592673-2AB09DF0-6B52-431F-9801-BC5D01B65D27 Q34613907-454F7C53-3D10-4D8A-B760-218BACE37466 Q34614067-18406A79-0B79-478D-841F-1640E072416C Q35554218-7303DB8B-C9C9-4FC6-9B39-F00B6CEB5CB4 Q35554475-C26FD9A3-27D9-4DE7-90ED-E06B1DC86030 Q35554794-142F7543-B599-4DA5-B004-80CB7F2A34F2 Q35554918-FFD69C3B-952C-41C2-8425-451FB3C366F3 Q35555451-2ACACBE6-98C5-4913-8B6A-7D52F306B672 Q35555465-CF56FCEC-7998-43C9-9C81-46004EFCC0E0 Q35555833-30D023BD-2C0D-4581-88AB-D62961D2E923 Q35605461-D6312CC5-D05B-4F97-9D1C-D50FA87154DC Q35630037-AD120407-5D7A-452A-95D0-890313D6CBEE Q35636900-9488BE5B-0587-4C2C-BF97-70B1309A3ABC Q35637012-FE55C392-6625-4BFA-895A-7859811A39F7 Q35637293-3DB8408E-48FC-4E6E-AC4F-6760DF8B5469 Q35638233-BBA99126-C41A-4F19-B69D-D93049D4FD1E Q35940404-890527CB-CB1E-4BD8-9DF2-F6DDB8BB296C Q36020178-24351F51-F6E5-4F7B-8320-9F2AAB070ED5 Q36210882-13B6E58C-A108-4D08-A364-5D6D8E5E5DB1 Q36226397-5ED0F7DD-2E22-4C66-B2C6-2E536AB098A9 Q36245711-85DAFDF1-110E-4E29-A366-D803E317B319 Q36292652-E316A810-E780-4038-B3F7-F7D8238A80C9 Q36349645-016B0A5A-D888-4E03-AA8A-D1A6F0BB76CC Q36365524-B3EADFF6-C67F-49A6-B696-E46326E7C30F Q36458447-92AC4298-0DBD-420D-B4A2-768D6201E1FC Q36611042-77777DE7-25EB-47DC-87BA-02DEBF987BDA Q36773202-7DBF2232-07AB-4EFB-A0BF-1B47DF3126A9 Q36907291-0E867BA7-E78E-4955-8FC5-D51BD94B65A6

P2860

Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis, before and after successful therapy with infliximab: evaluation of a new scoring system.

http://www.wikidata.org/entity/Q44398382

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh-hant

name

Magnetic resonance imaging exa ...... ation of a new scoring system.

@en

Magnetic resonance imaging exa ...... ation of a new scoring system.

@nl

type

label

Magnetic resonance imaging exa ...... ation of a new scoring system.

@en

Magnetic resonance imaging exa ...... ation of a new scoring system.

@nl

prefLabel

Magnetic resonance imaging exa ...... ation of a new scoring system.

@en

Magnetic resonance imaging exa ...... ation of a new scoring system.

@nl

P1433

Q44398382-7B1DD696-1CA1-4EE0-80B5-63787E23A03D

P1476

Q44398382-32D2B3CF-121E-47B8-9DF3-7FC9CD0DBB56

P2093

Q44398382-462064F2-A995-40CD-963F-9AB8DAD38242

Q44398382-4C3BF050-C935-4E31-ACFA-F42E57665E98

Q44398382-7093EC6B-E4D9-4698-A69E-9087CD50DADF

Q44398382-82C93285-7D2F-40F8-8ECC-AFD3666FF17A

Q44398382-865B4408-3727-4122-803D-A0A771B9148D

Q44398382-B62DBA90-F4FA-4970-B77D-E754FFEF3269

Q44398382-BCA7E431-2089-4B9B-B0E7-7939003B10C4

Q44398382-CAB63C82-B500-40A8-A5BE-8E9F6B131D93

Q44398382-F5C7A08B-08C8-44BA-B570-C14CBDF29057

P304

Q44398382-3CDEBDA4-014C-4243-9F15-280760403DA2

P31

Q44398382-83334464-3941-4EEB-B164-0FAAC27234C4

P356

Q44398382-90394658-7A3C-426D-9464-61F71E1AE642

P433

Q44398382-308CD1B5-C38A-4C04-B007-487111E2EEC6

P478

Q44398382-E97DB657-0A3E-407A-81FF-CFA84BF0ED6D

P577

Q44398382-89CFC00B-10B2-4971-A652-A1868D9F9E79

P5875

Q44398382-4BA75608-12BF-4CD7-8F1B-915DC170188B

P698

Q44398382-7144F7B9-14A1-4223-A315-2AC51B05567F

P921

Q44398382-3C813C2F-12C9-45FB-B579-0FDD7D740AE2

P356

P1433

Arthritis & Rheumatology

P1476

Magnetic resonance imaging exa ...... ation of a new scoring system.

@en

P2093

Baraliakos X

http://www.w3.org/2001/XMLSchema#string

Bollow M

http://www.w3.org/2001/XMLSchema#string

Brandt J

http://www.w3.org/2001/XMLSchema#string

Braun J

http://www.w3.org/2001/XMLSchema#string

Golder W

http://www.w3.org/2001/XMLSchema#string

Listing J

http://www.w3.org/2001/XMLSchema#string

Rudwaleit M

http://www.w3.org/2001/XMLSchema#string

Sieper J

http://www.w3.org/2001/XMLSchema#string

Van Der Heijde D

http://www.w3.org/2001/XMLSchema#string

P304

1126-1136

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ART.10883

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

48

http://www.w3.org/2001/XMLSchema#string

P577

2003-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10811076

http://www.w3.org/2001/XMLSchema#string

P698

12687557

http://www.w3.org/2001/XMLSchema#string

P921